If AEGY is the kite, then SKTO is the tail of the kite. Pharmajanes catches the wind of public interest and rises. The more successful Pharmajanes is in attracting orders under that banner, the more SK will benefit through its branding, licensing and collective agreements. It's a big win win for both tickers.